Rani Therapeutics
RANI
RANI
37 hedge funds and large institutions have $10.7M invested in Rani Therapeutics in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.53% more ownership
Funds ownership: 12.73% → 13.26% (+0.53%)
2% less capital invested
Capital invested by funds: $10.9M → $10.7M (-$200K)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
37
Holding in Top 10
1
Calls
$123K
Puts
$70K
Top Buyers
| 1 | +$256K | |
| 2 | +$82.9K | |
| 3 | +$70K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$53.7K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$52.7K |
Top Sellers
| 1 | -$79.4K | |
| 2 | -$24.7K | |
| 3 | -$22.8K | |
| 4 |
PCIA
Prime Capital Investment Advisors
Overland Park,
Kansas
|
-$8.71K |
| 5 |
IWP
IAG Wealth Partners
Waukesha,
Wisconsin
|
-$3.34K |